Ontario has just announced that it will be getting a new Toronto vaccine facility that will help us become "self-sufficient" by the next pandemic flu. \nIn a press conference on Wednesday, it was announced that Sanofi, a global biopharmaceutical company, will be building a new facility in Canada to produce more flu vaccines. \nEditor's Choice: A 'Kim's Convenience' Spin-Off Is In The Works & One Character Is Heading To Hamilton\n\nWe are proud to announce our investment in a new facility on our current Toronto site @SanofiCanada. We will be able to produce more antigen for #influenza vaccines tailored to older adults, and increase their availability in Canada, the US and Europe. https://t.co/qCxqolZXJg pic.twitter.com/J2YGckcTkF— Sanofi (@sanofi) March 31, 2021\n\nThe Ontario government states that they will be able to "bulk manufacture Fluzone® High-Dose Quadrivalent Influenza Vaccine," which is a flu vaccine that is currently meant for people 65 years old and older. \n"When the next pandemic hits, whatever it might be, we will be prepared as a nation," states François-Philippe Champagne, minister of innovation, science and industry. \nThe new facility, which is expected to open in 2026, will also make the province a "strong candidate" for other vaccine production in the future.